According to the report, it was unclear for how long has the AstraZeneca sold its holding in Moderna.
AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company's shares soared on the back of its coronavirus vaccine breakthrough, The Times reported. According to the report, it was unclear for how long has the AstraZeneca sold its holding in Moderna.
The report added that the British-based AstraZeneca is retaining partnership with Moderna on other disease treatments. It could sell its AstraZeneca/Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic. Moderna got clearance for emergency usage against COVID-19 in the United States. It said last week that it was expecting sales of $18.4 billion from its coronavirus vaccine this year.
The Brief. Sign up to receive the top stories you need to know right now.